These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 779281)

  • 21. [Lonazolac - a new non-steroidal antirheumatic agent. Report of a double-blind crossover clinical study].
    Trnavský K; Bosmanský K
    Fysiatr Revmatol Vestn; 1983 Jun; 61(3):147-52. PubMed ID: 6350135
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of rheumatoid arthritis with pirprofen. Comparison of 2 dosage regimens].
    Camus JP; Prier A
    Nouv Presse Med; 1982 Aug; 11(33):2481-3. PubMed ID: 7133972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indoprofen compared with naproxen and placebo in rheumatoid arthritis.
    Berry H; Fernandes L; Clarke AK; Hamilton EB; Davies J; Dixon AS
    Eur J Rheumatol Inflamm; 1981; 4(1):87-92. PubMed ID: 7042367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lonazolac-Ca-a non-steroidal antirheumatic agent. Long-term clinical study in chronic polyarthritis].
    Lonauer G; Wagner H; Boerngen U; Goebel KM
    Z Rheumatol; 1981; 40(4):161-4. PubMed ID: 7027681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methoxypropriocin (RS-3540); clinical study on 40 patients suffering from rheumatoid arthritis.
    Lussier A; Regoli D; Gysling E; Boost G; Varady JC
    Int J Clin Pharmacol; 1973 Feb; 7(1):6-12. PubMed ID: 4573017
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lonazolac-Calcium. A new non-steroidal antirheumatic agent for the treatment of progressive polyarthritis. A long-term open controlled trial].
    Pavelka K
    Fysiatr Revmatol Vestn; 1984 Apr; 62(2):80-7. PubMed ID: 6378745
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical study of a new anti-inflammatory drug: 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Dotti F; Ongari R; Carazzi R; Chierichetti S
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:265-8. PubMed ID: 4553235
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effectiveness of non-steroidal anti-inflammatory and psychotropic drugs in patients with rheumatoid arthritis].
    Korshunov NI; Baranova EIa
    Ter Arkh; 1984; 56(11):77-81. PubMed ID: 6395430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical experiences with a new non-steroid antirheumatic agent].
    Carcassi A
    Minerva Med; 1973; 64(45):2361-4. PubMed ID: 4733891
    [No Abstract]   [Full Text] [Related]  

  • 30. A double-blind crossover trial comparing a new antirheumatic agent alclofenac with phenylbutazone in chronic rheumatic disorders.
    Anylward M; Davies DB
    Br J Clin Pract; 1972 Nov; 26(11):517-23. PubMed ID: 4563533
    [No Abstract]   [Full Text] [Related]  

  • 31. Double-blind clinical trial of protacine versus oxyphenbutazone in rheumatic disorders.
    Loizzi P; Pipitone V; Bignamini AA
    Pharmatherapeutica; 1980; 2(5):285-92. PubMed ID: 7001487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A multicenter study on the effectiveness of non-steroidal anti- inflammatory agents associated with nandrolone decanoate in the management of osteoarthritis and rheumatoid arthritis].
    Caniggia A
    Minerva Med; 1983 Nov; 74(45-46):2737-99. PubMed ID: 6366616
    [No Abstract]   [Full Text] [Related]  

  • 33. [Statistical evaluation of the therapeutic effect of a new antirheumatic drug, mefenamic acid, on rheumatoid arthritis].
    Colombo B; Mantellini P; Caruso I
    Reumatismo; 1967; 19(5):317-27. PubMed ID: 5617956
    [No Abstract]   [Full Text] [Related]  

  • 34. Benefits of low-dose corticosteroids in rheumatoid arthritis.
    Cohen MD; Conn DL
    Bull Rheum Dis; 1997 Jun; 46(4):4-7. PubMed ID: 9188203
    [No Abstract]   [Full Text] [Related]  

  • 35. Piroxicam suppositories for osteoarthritis and rheumatoid arthritis: an open multicentre study in 116 patients.
    Heynen G; Dessain P
    Eur J Rheumatol Inflamm; 1983; 6(1):134-8. PubMed ID: 6345164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)].
    Warnatz H; Scheiffarth F; Gutmann W
    Med Klin; 1975 Sep; 70(38):1509-15. PubMed ID: 810648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimentation and clinical evaluation of ibuprofen, a new synthetic non-steroid antirheumatic agent].
    Perpignano G
    Minerva Med; 1973 Jun; 64(47):2471-4. PubMed ID: 4579838
    [No Abstract]   [Full Text] [Related]  

  • 38. [The role of disease-modifying antirheumatic drugs (DMARDs) in the therapy of rheumatoid arthritis].
    Cervini C; Salaffi F; Peroni M
    Clin Ter; 1993 Jan; 142(1):3-18. PubMed ID: 8472508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benorylate and indomethacin in the treatment of rheumatoid disease: a double-blind clinical trial.
    Franke M; Manz G
    Curr Ther Res Clin Exp; 1972 Mar; 14(3):113-22. PubMed ID: 4622890
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative clinical trial with a new substance, Diftalone, versus indomethacin in 30 patients affected with rheumatoid arthritis.
    Tausch G; Bröll H; Dunky A; Eberl R
    Scand J Rheumatol; 1976; 5(3):145-50. PubMed ID: 824725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.